Sign in
Not yet recruitingNo phase

Nerve, autonomic and ultrasound checks for nerve damage in people with diabetes

Tests combined nerve, autonomic and ultrasound assessments in adults with diabetic peripheral neuropathy.

Key facts

Who runs it
Assiut University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Neurophysiological, Autonomic, and Sonographic Assessment of Diabetic Peripheral Neuropathy
Status
Not yet recruiting
People taking part
75 people, planned
Started
Jan 2026
Expected to end
Feb 2027
Type of study
Interventional, 3 groups
Treatments tested
  • Nerve conduction study
  • Nerve ultrasound
  • Autonomic assessment
Record updated
29 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 1 or type 2 diabetes, with or without nerve damage in the feet and legs (diabetic peripheral neuropathy). It also takes healthy people of similar age and sex for comparison.

Age
18 to 75 years
Sex
All sexes
Disease stage
Type 1 or type 2 diabetes, with or without nerve damage. Healthy volunteers can also join.

Main reasons for not taking part

  • Nerve damage from another cause, such as CIDP, injury, toxins or low vitamin levels
  • Advanced kidney failure
  • Thyroid disease or long-term heavy alcohol use
  • Pregnancy
  • An implanted heart device that may disturb the nerve tests

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Adults aged 18-75 years with type 1 or type 2 diabetes (with or without diabetic peripheral neuropathy), and age and sex-matched healthy controls

Who cannot take part

  • Other causes of neuropathy (e.g., CIDP, trauma, toxins, vitamin deficiencies), advanced renal failure,thyroid disease,chronic alcohol use, pregnancy,
  • presence of implanted cardiac devicesthat may interfere with autonomic testing

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Diabetic peripheral neuropathy causes pain, sensory loss, and foot risk; multimodal assessment enables earlier diagnosis and improved patient management.

The 3 groups in the trial

  • Diabetic patients with symptomatic peripheral neuropathy.Other group

    Treatment: Nerve conduction study and Nerve ultrasound

  • Diabetic without any clinical features nor complaints of peripheral neuropathyOther group

    Treatment: Nerve conduction study, Nerve ultrasound, and Autonomic assessment

  • Healthy individuals.Other group

    Treatment: Nerve conduction study, Nerve ultrasound, and Autonomic assessment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Neurophysiological, Autonomic, and Sonographic Assessment of Diabetic Peripheral Neuropathy
Plain-language title
Nerve, autonomic and ultrasound checks for nerve damage in people with diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT07306884, who can take part
Record updated
29 December 2025